The Canaries Are All Dead

By KIM BELLARD MIT is, most people would admit, a pretty good school.  Even those who don’t know a lot about universities probably associate MIT with science, engineering, and math, and in fact, it is one of the leading universities in the world for those (and other) areas. E.g., the QS World University Rankings have…

Read More

Links

Ebola outbreak in the Congo.AI Mathematicians.Why Long-Term Care Policy Keeps Failing.ISPOR: first, second and third plenary.The Indiana Bears?

Read More

ICE Arrests Are Separating Families. Here’s How To Plan Ahead.

President Donald Trump’s immigration crackdown has parents who lack legal residency worried about the welfare of children left behind. Some jurisdictions are taking action. Maryland, Virginia, and Washington, D.C., allow families to name temporary guardians if a parent is detained or deported. KFF Health News correspondent Jazmin Orozco Rodriguez appeared on WAMU’s May 13 Health…

Read More

Watch: The Tug-of-War Over Taxpayer Dollars

Julie Rovner, KFF Health News’ chief Washington correspondent and host of the What the Health? podcast, recently spoke with Sen. Tammy Baldwin (D-Wis.) about the ongoing fight between President Donald Trump and Congress over control of federal spending. Baldwin, who is a member of the Senate Appropriations Committee and the Senate Health, Education, Labor and…

Read More

Dor Skuler, Intuition Robotics: Meet EllieQ

Dor Skuler is CEO of Intuition Robotics the maker of EllieQ — a remarkable AI robot that is a companion for seniors. I had a lot of fun meeting ElliQ and asking Dor about how she works. This is a wide-ranging interview with Dor and with EllieQ. She tells us about Florence Nightingale, what Dor…

Read More

Medicare Drug Price Negotiation is here to stay

At least, it won’t be overturned by the US Supreme Court. Endpoints reports: The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Novo Nordisk, Novartis and Boehringer Ingelheim… The…

Read More